A Novel TEAD2 Variant Disrupts Eye Development Resulting in Microphthalmia and Ocular Coloboma
Ophthalmology Science · 2026-12 · 6 (12) · 101423
DOI: 10.1016/j.xops.2026.101423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Science, 2026-12. Verfasst von Jonathan Eintracht und 5 weiteren Autor:innen. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for the Replacement Refinement & Reduction of Animals in Research, Moorfields Eye Charity, NIHR Moorfields Biomedical Research Centre.
Abstract (Originalsprache)
Transcription factors (TFs), other regulatory genes and morphogens are involved in highly conserved gene regulatory networks (GRNs), such as Wnt, Sonic hedgehog (SHH), bone morphogenesis protein (BMP), fibroblast growth factor (FGF) and retinoic acid [1,2]. These networks drive the development of the eye, initially through eye-field specification in the anterior neural plate and optic vesicle (OV) evagination [3]: the OV interacts with the surface ectoderm, integrates signals from BMP and retinoic acid pathways that provide cues for optic cup formation [4,5]. Integrated signals from early developmental pathways such as Wnt, notch and transforming growth factor beta (TGF-β) facilitate the patterning of the optic cup along the proximodistal, nasotemporal and dorsoventral axes, giving rise to structures such as the neural retina (NR), retinal pigment epithelial (RPE), optic nerve, lens and cornea in the rudimentary eye [6]. Disruptions to these GRNs between 4-7 weeks post-conception can result in ocular malformation. The disease spectrum of microphthalmia (small eye), anophthalmia (absence of the eye) and ocular coloboma (incomplete fusion of the optic fissure), known collectively as MAC, is one of the most common developmental eye disorders that contributes to between 10-20% of childhood blindness cases worldwide [7–9]. Seldomly attributed to environmental causes, these disorders are largely caused by pathogenic variants reported in over 100 genes [10–13] with the highest proportion reported in TFs and regulators that have major roles in these GRNs [14,15]. TFs are critical for development as they control gene expression and direct cell fate decisions through transcriptomic regulation in virtually every cell in the body[16,17]. Although TFs often have specific spatiotemporal domains of expression, previously undiscovered functions are continuously detected such as the novel role of MITF in organelle biogenesis and homeostasis, and LHX2 in regulation of chromatin availability in retinal progenitors [18,19]. Additionally, novel variants are continually detected in transcription factors, creating new associations with disease, such as the missense variant c.372C>A, p.Asn124Lys in PAX6 causing bilateral microphthalmia [20–22]. A recent real-world study reported that only one-third of MAC patients will receive a molecular diagnosis irrespective of laterality and symmetry [23], but whole genome sequencing (WGS) has the potential to increase this rate by a further 40% and is an effective strategy for the discovery of novel candidate MAC genes [24]. Other studies utilising cross-species meta-analysis with patient genomic data have led to the identification of novel MAC genes [25]. In diseases with low diagnostic rates like MAC, the clinical relevance of variants is often unclear as their relationship with human disease has not yet been determined [25]. However, it is possible to integrate both WGS and RNA-seq techniques to identify novel variants and genes in patient-derived tissue, such as the identification of deep intronic variants in CNGB3 associated with inherited retinal disease [26,27]. These studies demonstrated how the use of patient-specific human induced pluripotent stem cell (hiPSC)-derived retinal organoids could maintain similar tissue-specific transcriptomic profiles as native tissue to enable detection of pathogenic variants [27]. The inaccessibility of human foetal retinal tissue is a considerable barrier for tissue-specific investigation of MAC, thus alternative models such as hiPSC-derived OVs are useful[28]. Many studies have assessed the fidelity of in vitro modelling of ocular development to human foetal eye development, suggesting these stem cell-derived models have a similar transcriptomic profile to human tissue at corresponding timepoints [29–33]. In this article, a single family with microphthalmia and ocular coloboma was studied to identify the likely disease-causing variant, with WGS and transcriptomic analyses, after exclusion of targeted gene panels. Zebrafish and hiPSC-derived OV models were created to provide evidence of pathophysiology to highlight novel disease mechanisms associated with the MAC clinical spectrum.
Förderung
- National Centre for the Replacement Refinement & Reduction of Animals in Research
- Moorfields Eye Charity
- NIHR Moorfields Biomedical Research Centre
- Wellcome Trust
Zitieren
APA
Eintracht, J., Owen, N., Toms, M., Chan, B. H. C., Rainger, J., & Moosajee, M. (2026). A Novel TEAD2 Variant Disrupts Eye Development Resulting in Microphthalmia and Ocular Coloboma. Ophthalmology Science, 6(12), 101423. https://doi.org/10.1016/j.xops.2026.101423
Vancouver
Eintracht J, Owen N, Toms M, Chan BHC, Rainger J, Moosajee M. A Novel TEAD2 Variant Disrupts Eye Development Resulting in Microphthalmia and Ocular Coloboma. Ophthalmology Science. 2026;6(12):101423. doi:10.1016/j.xops.2026.101423
BibTeX
@article{Eintracht2026,
author = {Eintracht, Jonathan and Owen, Nicholas and Toms, Maria and Chan, Brian Ho Ching and Rainger, Joe and Moosajee, Mariya},
title = {A Novel TEAD2 Variant Disrupts Eye Development Resulting in Microphthalmia and Ocular Coloboma},
journal = {Ophthalmology Science},
year = {2026},
volume = {6},
number = {12},
pages = {101423},
doi = {10.1016/j.xops.2026.101423}
}
EUVIMED